Apellis Pharmaceuticals
APLS
#3905
Rank
NZ$3.84 B
Marketcap
$30.62
Share price
0.22%
Change (1 day)
-61.95%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Apellis Pharmaceuticals CIK: 0001492422

Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail Apellis Pharmaceuticals 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)